3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α 7 receptors and improves memory-related behaviors in a mecamylamine- sensitive manner

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 49-56

  Meyer, Edwin M ^a   Tay, Ee Tein ^a   Papke, Roger L ^a   Meyers, Craig ^a   Huang, Guang Ling ^a   De Fiebre, Christopher M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Morris water task; Nicotinic receptor; Passive avoidance; Xenopus oocyte

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACETYLCHOLINE; BUNGAROTOXIN; IBOTENIC ACID; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; MALE; NEOCORTEX; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

ANIMALS; AVOIDANCE LEARNING; BENZYLIDENE COMPOUNDS; MALE; MAZE LEARNING; MECAMYLAMINE; MEMORY; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 0002100551     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00536-2     Document Type: Article

References (30)

1. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distince structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1469.
2. Arneric S.P., Sullivan J.P., Briggs C.A., Donnelly-Roberts D., Anderson D.J., Raszkiewicz J.L., Hughes M.L., Cadman E.D., Adams P., Garvey D.S.et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition enhancing and anxiolytic activities. I. In vitro characterization. J. Pharmacol. Exp. Ther. 270:1994;310-318.
3. 125I]α-bungarotoxin. J. Neurosci. 5:1985;1307-1315.
4. Connor D.J., Langlais P.J., Thal L.J. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res. 555:1991;84-90.
5. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Miller N., Soledad V., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (α-7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-bungarotoxin. Neuron. 5:1990;8476-8856.
6. Decker M.W., Brioni J.D., Sullivan J.P., Buckley M.J., Radek R.J., Raszkiewicz J.L., Kang C.H., Kim D.J., Giardina W.J., Wasicak J.T.et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition enhancing and anxiolytic activities. J. Pharmacol. Exp. Ther. 270:1994;319-328.
7. de Fiebre C.M., Meyer E.M., Kem W., Papke R.L. Characterization of a family of anabaseine-derived compounds reveals that the 3-(4)-dimethylamino-cinnamylideine derivative is a selective agonist at neuronal nicotinic α7/α-bungarotoxin receptor subtypes. Mol. Pharmacol. 47:1995;164-171.
8. Dekker A.J., Gage F.H., Thal L.J. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience. 48:1992;111-119.
9. Deneris E.S., Connolly J., Rogers S.W., Duvoisin R. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 12:1991;34-40.
10. W.J. Dixon, F.J. Massey, Introduction to Statistical Analyses, McGraw-Hill, New York, 1969.
11. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41:1992;31-37.
12. J.E. Henningfield, S.R. Goldberg, Stimulus properties of nicotine in animals and human volunteers: a review, in: L.S. Seiden, R.L. Balster (Eds.), Behavioral Pharmacology: The Current Status, Alan R. Liss, New York, 1984, pp. 433-449.
13. Hunter B.H., Papke R.L., de Fiebre C.M., Meyer E.M. Facilitation of hippocampal LTP by an apparent α7 nicotinic agonist. Neurosci. Lett. 168:1994;130-134.
14. B.E. Hunter, S.F. Zornetzer, M.E. Jarvik, J.L. McGaugh, Modulation of learning and memory: effects of drugs influencing neurotransmitters, in: L.L. Iversen, S.D. Iversen, S.H. Snyder (Eds.), Drugs, Neurotransmitters, and Behavior, Handbook of Psychopharmacology, vol. 8, Plenum Press, New York, 1977, pp. 531-577.
15. Marks M.J., Stitzel J.A., Romm E., Wehner J.J., Collins A.C. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine and α-bungarotoxin. Mol. Pharmacol. 30:1986;427-436.
16. Martin E.J., Panicker K.S., King M.A., Deyrup M., Hunter B.E., Meyer E.M. Cytoprotective action of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev. Res. 31:1994;127-134.
17. Meyer E.M., Arendash G.W., Judkins J., Ying L., Wade K., Kem W.R. Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of acetylcholine release in the rat cerebral cortex. J. Neurochem. 49:1987;1758-1762.
18. Meyer E.M., de Fiebre C.M., Hunter B.E., Simpkins C.E., de Fiebre N.E. Effects of anabaseine related analogs on rat brain nicotinic receptor binding and on avoidance behavior. Drug Dev. Res. 31:1994;135-141.
19. Morris R.G.M. Spatial localization does not require the presence of local cues. Learn. Motiv. 12:1981;239-260.
20. Newhouse P.A., Sunderland T., Tariot P.N., Blumhardt C.L., Weingartner H., Mellow A., Murphey D.L. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology. 95:1988;171-175.
21. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 39:1990;9-12.
22. Page K.J., Everitt B.J., Robbins T.W., Marston H.M., Wilkiinson L.S. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA and ibotenic acid induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience. 43:1991;457-472.
23. Papke R.L. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog. Neurobiol. 41:1993;509-531.
24. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Orlando, FL, 1986.
25. Paylor R., Rudy J.W. Cholinergic receptor blockade can impair the rat's performance on both the place learning and cued versions of the Morris water task: the role of age and pool wall brightness. Behav. Brain. Res. 36:1990;79-90.
26. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry. 154:1989;797-805.
27. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;595-604.
28. D.M. Warburton, Psychopharmacological aspects of nicotine, in: S. Wonnacott, M.A.H. Russell, I.P. Stolerman (Eds.), Nicotine Psychopharmacology, Molecular, Cellular and Behavioral Aspects, Oxford University Press, New York, 1990, pp. 77-111.
29. D.S. Woodruf-Pak, Y.-T. Li, W.R. Kem, A nicotinic agonist (GTS-21), eyeblink classical conditioning and nicotinic receptor binding in rabbit brain, Brain Res. (1997) in press.
30. Zoltewicz J.A., Prokai-Tatrai K., Bloom L.B., Kem W.R. Long range transmission of polar effects in cholinergic 3-arylidene anabaseines. Conformations calculated by molecular modeling. Heterocyclics. 35:1993;171-179.